J. A. Gray and B. L. Roth, Molecular targets for treating cognitive dysfunction in schizophrenia, Schizophr Bull, vol.33, issue.5, pp.1100-1119, 2007.

H. Y. Meltzer, B. W. Massey, and M. Horiguchi, Serotonin receptors as targets for drugs useful to treat psychosis and cognitive impairment in schizophrenia, Curr Pharm Biotechnol, vol.13, issue.8, pp.1572-86, 2012.

R. Keefe, R. M. Bilder, S. M. Davis, P. D. Harvey, B. W. Palmer et al., Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial. Arch Gen Psychiatry, vol.64, pp.633-680, 2007.

A. Ellaithy, J. Younkin, J. González-maeso, and D. E. Logothetis, Positive allosteric modulators of metabotropic glutamate 2 receptors in schizophrenia treatment, Trends Neurosci, vol.38, issue.8, pp.506-522, 2015.

J. Gibert-rahola and A. Villena-rodriguez, Glutamatergic drugs for schizophrenia treatment, Actas Esp Psiquiatr, vol.42, issue.5, pp.234-275, 2014.

M. J. Fell, D. L. Mckinzie, J. A. Monn, and K. A. Svensson, Group II metabotropic glutamate receptor agonists and positive allosteric modulators as novel treatments for schizophrenia, Neuropharmacology, vol.62, issue.3, pp.1473-83, 2012.

B. J. Kinon, B. A. Millen, L. Zhang, and D. L. Mckinzie, Exploratory analysis for a targeted patient population responsive to the metabotropic glutamate 2/3 receptor agonist pomaglumetad methionil in schizophrenia, Biol Psychiatry, vol.78, issue.11, pp.754-62, 2015.

G. J. Marek, R. A. Wright, D. D. Schoepp, J. A. Monn, and G. K. Aghajanian, Physiological antagonism between 5-hydroxytryptamine(2A) and group II metabotropic glutamate receptors in prefrontal cortex, J Pharmacol Exp Ther, vol.292, issue.1, pp.76-87, 2000.

J. González-maeso, R. L. Ang, T. Yuen, P. Chan, N. V. Weisstaub et al., Identification of a serotonin/glutamate receptor complex implicated in psychosis, Nature, vol.452, issue.7183, pp.93-100, 2008.

J. L. Moreno, P. Miranda-azpiazu, A. García-bea, J. Younkin, M. Cui et al., Allosteric signaling through an mGlu2 and 5-HT2A heteromeric receptor complex and its potential contribution to schizophrenia, Sci Signal, vol.9, issue.410, p.5, 2016.

M. Fribourg, J. L. Moreno, T. Holloway, D. Provasi, L. Baki et al., Decoding the signaling of a GPCR heteromeric complex reveals a unifying mechanism of action of antipsychotic drugs, Cell, vol.147, issue.5, pp.1011-1034, 2011.

H. K. Delille, M. Mezler, and G. J. Marek, The two faces of the pharmacological interaction of mGlu2 and 5-HT?A -relevance of receptor heterocomplexes and interaction through functional brain pathways, Neuropharmacology, vol.70, pp.296-305, 2013.

A. J. Butcher, K. C. Kong, R. Prihandoko, and A. B. Tobin, Physiological role of G-protein coupled receptor phosphorylation, Handb Exp Pharmacol, issue.208, pp.79-94, 2012.

S. Karaki, C. Becamel, S. Murat, M. La-cour, C. Millan et al., Quantitative phosphoproteomics unravels biased phosphorylation of serotonin 2A receptor at Ser280 by hallucinogenic versus nonhallucinogenic agonists, Mol Cell Proteomics MCP, vol.13, issue.5, pp.1273-85, 2014.

H. Schaffhauser, Z. Cai, F. Hubalek, T. A. Macek, J. Pohl et al., cAMPdependent protein kinase inhibits mGluR2 coupling to G-proteins by direct receptor phosphorylation, J Neurosci Off J Soc Neurosci, vol.20, issue.15, pp.5663-70, 2000.

R. J. Lefkowitz, K. L. Pierce, and L. M. Luttrell, Dancing with different partners: protein kinase a phosphorylation of seven membrane-spanning receptors regulates their G proteincoupling specificity, Mol Pharmacol, vol.62, issue.5, pp.971-975, 2002.

R. Schrage, A. Schmitz, E. Gaffal, S. Annala, S. Kehraus et al., The experimental power of FR900359 to study Gq-regulated biological processes, Nat Commun, vol.6, p.10156, 2015.

C. Bécamel, S. Gavarini, B. Chanrion, G. Alonso, N. Galéotti et al., The serotonin 5-HT2A and 5-HT2C receptors interact with specific sets of PDZ proteins, J Biol Chem, vol.279, issue.19, pp.20257-66, 2004.

S. Gaillard, L. Lo-re, A. Mantilleri, R. Hepp, L. Urien et al., G?iinteracting protein, functions as a key modulator of peripheral GABAB receptormediated analgesia, Neuron, vol.84, issue.1, pp.123-159, 2014.

F. Dubois, F. Vandermoere, A. Gernez, J. Murphy, R. Toth et al., Differential 14-3-3 affinity capture reveals new downstream targets of phosphatidylinositol 3-kinase signaling, Mol Cell Proteomics MCP, vol.8, issue.11, pp.2487-99, 2009.

J. González-maeso, T. Yuen, B. J. Ebersole, E. Wurmbach, A. Lira et al., Transcriptome fingerprints distinguish hallucinogenic and nonhallucinogenic 5-hydroxytryptamine 2A receptor agonist effects in mouse somatosensory cortex, J Neurosci Off J Soc Neurosci, vol.23, issue.26, pp.8836-8879, 2003.

M. Yokoi, K. Kobayashi, T. Manabe, T. Takahashi, I. Sakaguchi et al., Impairment of hippocampal mossy fiber LTD in mice lacking mGluR2, Science, 1996.

B. Chanrion, C. Mannoury-la-cour, S. Gavarini, M. Seimandi, L. Vincent et al., Inverse agonist and neutral antagonist actions of antidepressants at recombinant and native 5-hydroxytryptamine2C receptors: differential modulation of cell surface expression and signal transduction, Mol Pharmacol, vol.73, issue.3, p.28, 2008.

H. K. Delille, J. M. Becker, S. Burkhardt, B. Bleher, G. C. Terstappen et al., Heterocomplex formation of 5-HT2A-mGlu2 and its relevance for cellular signaling cascades, Neuropharmacology, vol.62, issue.7, pp.2184-91, 2012.

. Miner-l-a.-h, J. R. Backstrom, E. Sanders-bush, and S. R. Sesack, Ultrastructural localization of serotonin2A receptors in the middle layers of the rat prelimbic prefrontal cortex, Neuroscience, vol.116, issue.1, pp.107-124, 2003.

Y. Xue, J. Ren, X. Gao, J. C. Wen, L. Yao et al., GPS 2.0, a tool to predict kinase-specific phosphorylation sites in hierarchy, Mol Cell Proteomics MCP, vol.7, issue.9, pp.1598-608, 2008.

G. Rena, J. Bain, M. Elliott, and P. Cohen, D4476, a cell-permeant inhibitor of CK1, suppresses the site-specific phosphorylation and nuclear exclusion of FOXO1a, EMBO Rep, vol.5, issue.1, pp.60-65, 2004.

L. C. Russo, L. M. Castro, F. C. Gozzo, and E. S. Ferro, Inhibition of thimet oligopeptidase by siRNA alters specific intracellular peptides and potentiates isoproterenol signal transduction, FEBS Lett, vol.586, pp.3287-92, 2012.

S. C. Sealfon, L. Chi, B. J. Ebersole, V. Rodic, D. Zhang et al., Related contribution of specific helix 2 and 7 residues to conformational activation of the serotonin 5-HT2A receptor, J Biol Chem, vol.270, issue.28, pp.16683-16691, 1995.

W. Chen and A. L. Kirchgessner, Activation of group II mGlu receptors inhibits voltagegated Ca2+ currents in myenteric neurons, Am J Physiol Gastrointest Liver Physiol, vol.283, issue.6, pp.1282-1289, 2002.

G. W. Zamponi, E. Bourinet, D. Nelson, J. Nargeot, and T. P. Snutch, Crosstalk between G proteins and protein kinase C mediated by the calcium channel alpha1 subunit, Nature, vol.385, issue.6615, pp.442-448, 1997.

R. T. Premont and R. R. Gainetdinov, Physiological roles of G protein-coupled receptor kinases and arrestins, Annu Rev Physiol, vol.69, pp.511-545, 2007.

E. Reiter, S. Ahn, A. K. Shukla, and R. J. Lefkowitz, Molecular mechanism of ?-arrestin-biased agonism at seven-transmembrane receptors, Annu Rev Pharmacol Toxicol, vol.52, pp.179-97, 2012.
URL : https://hal.archives-ouvertes.fr/hal-01129592

K. N. Nobles, K. Xiao, S. Ahn, A. K. Shukla, C. M. Lam et al., Distinct phosphorylation sites on the ?(2)-adrenergic receptor establish a barcode that encodes differential functions of ?-arrestin, Sci Signal, vol.4, issue.185, p.51, 2009.

A. J. Butcher, R. Prihandoko, K. C. Kong, P. Mcwilliams, J. M. Edwards et al.,

, Differential G-protein-coupled receptor phosphorylation provides evidence for a signaling bar code, J Biol Chem, vol.286, issue.13, pp.11506-11524, 2011.

J. M. Busillo, A. S. Sengupta, R. Meucci, O. Bouvier, M. Benovic et al., Site-specific phosphorylation of CXCR4 is dynamically regulated by multiple kinases and results in differential modulation of CXCR4 signaling, J Biol Chem, vol.285, issue.10, pp.7805-7822, 2010.

J. W. Wisler, S. M. Dewire, E. J. Whalen, J. D. Violin, M. T. Drake et al., A unique mechanism of beta-blocker action: carvedilol stimulates beta-arrestin signaling, Proc Natl Acad Sci, vol.104, issue.42, pp.16657-62, 2007.

A. B. Tobin, A. J. Butcher, and K. C. Kong, Location, location, location...site-specific GPCR phosphorylation offers a mechanism for cell-type-specific signalling, Trends Pharmacol Sci, vol.29, issue.8, pp.413-433, 2008.

L. Moulédous, C. Froment, S. Dauvillier, O. Burlet-schiltz, J. Zajac et al., GRK2 protein-mediated transphosphorylation contributes to loss of function of ?-opioid receptors induced by neuropeptide FF (NPFF2) receptors, J Biol Chem, vol.287, issue.16, p.30, 2012.

J. L. Moreno, T. Holloway, L. Albizu, S. C. Sealfon, and J. González-maeso, Metabotropic glutamate mGlu2 receptor is necessary for the pharmacological and behavioral effects induced by hallucinogenic 5-HT2A receptor agonists, Neurosci Lett, vol.493, issue.3, pp.76-85, 2011.

J. González-maeso, N. V. Weisstaub, M. Zhou, P. Chan, L. Ivic et al., Hallucinogens recruit specific cortical 5-HT(2A) receptor-mediated signaling pathways to affect behavior, Neuron, vol.53, issue.3, pp.439-52, 2007.

F. Nicoletti, J. Bockaert, G. L. Collingridge, P. J. Conn, F. Ferraguti et al., Metabotropic glutamate receptors: from the workbench to the bedside

, Neuropharmacology, vol.60, pp.1017-1058, 2011.

U. Knippschild, A. Gocht, S. Wolff, N. Huber, J. Löhler et al., The casein kinase 1 family: participation in multiple cellular processes in eukaryotes, Cell Signal, vol.17, issue.6, pp.675-89, 2005.

Y. Yang, T. Xu, Y. Zhang, and X. Qin, Molecular basis for the regulation of the circadian clock kinases CK1? and CK1?. Cell Signal, vol.31, pp.58-65, 2017.

D. El-moustaine, S. Granier, E. Doumazane, P. Scholler, R. Rahmeh et al., Distinct roles of metabotropic glutamate receptor dimerization in agonist activation and G-protein coupling, Proc Natl Acad Sci, vol.109, issue.40, pp.16342-16349, 2012.

B. Dean, The cortical serotonin2A receptor and the pathology of schizophrenia: a likely accomplice, J Neurochem, vol.85, issue.1, pp.1-13, 2003.